Combined ANZCVS / EVA Clinical Papers
Submission closing date, 28 April 2023.
Abstracts to be presented at the combined ANZCVS / EVA session. Please note that accepted abstracts will be printed in The Australian Equine Veterinarian and The Proceedings of the ANZCVS Science Week. The abstracts can be recent research, clinical projects, or alternatively a case series or report involving any aspect of equine veterinary science.
Reviewing the submitted abstracts
Submitted abstracts will be peer-reviewed by a panel appointed by both EVA and the equine chapter of the ANZCVS, and if accepted, the author will be invited to present their abstract on Monday 17 July at the Bain Fallon Conference, Sunshine Coast Conference Centre, Novotel Twin Waters on Day One of the Bain Fallon Memorial Lectures 2023. A submission form should accompany every abstract, and multiple abstracts can be submitted.
Presentation time and prizes
The presentation time is 10 minutes with an additional two (2) minutes for questions and discussion. The purpose of the clinical papers is to inform attendees of clinical research or case experience that they can use in their own practices, for the benefit of clients and their horses.
A number of prizes will be on offer by both organisations for the best presentations. A presenter can only receive one EVA prize, although they can receive an EVA prize and the ANZCVS prize.
Notifications of accepted submissions
You will be notified by email in May 2023 if your abstract has been accepted.
Submissions
Please fill out the Abstract Submission Form and submit along with your abstract to Camilla Broughton camilla.broughton@ava.com.au
Important information for submissions
Please note that accepted abstracts will be printed in the Spring AEV Journal 2023 Bain Fallon and may appear in other EVA media. The clinical abstracts can be recent research, clinical projects, or alternatively a case series or individual case report involving any aspect of equine veterinary science. Submitted abstracts will have their authorship blinded and be peer-reviewed by a panel appointed by both EVA and the equine chapter of the ANZCVS.
A submission form should accompany every abstract, and multiple abstracts can be submitted by the same author/s. To assist with the blinding process please submit two (2) copies of the abstract, both as word documents. One with authorship clearly stated and the other blinded with the names of authors and clinic/company/organisation removed. All identifying comments should also be removed from the body of the abstract. If the abstract is not written in the correct format authors may be given the opportunity to resubmit the manuscript in the correct format, by 28th April 2023.
The abstract should be in the following format, being one page. It is the author’s responsibility to ensure they do not exceed the abstract word limit of 250 words.
1. Title (top line): Title bolded in cap Centred.
2. Authors and affiliations (2nd line): Names of authors with presenting author underlined (2nd line). Presenter’s clinic/company/organisation (3rd line). Centred.
3. Introduction
4. Materials and methods, or Case history (including any diagnostic tests/techniques and Animal Ethics Approval numbers for research papers)
5. Results, or Clinical outcome
6. Relevance to Australian clinical equine practice
(a paragraph on each of the items 3 to 6 should suffice)
Program: Microsoft Word
Paper size: A4 paper (21 x 29.7cm) one side only, using single line spacing
Font: Calibri
Font size: 11pt
Margins: LHS & RHS margins 3cm / Top & bottom margins 2.5cm Set language to English (Australian) and spell check accordingly.
Paragraphs: One line to be left between paragraphs and no indentation required.
Subheadings: Calibri, bold, 11pt.
The abstracts need to be informative, and such statements as “...results will be presented...” are unacceptable. All the information to be presented must be in the abstract. Any advertisements for commercial products must not be included; however, it is acceptable to mention registered drug names and dose rates if they are critical to the information presented. You are reminded that abstracts should not contain citations to published literature. Clinical papers that have previously been presented in Australasia or published in a peer-reviewed journal are unlikely to be considered for inclusion, and a declaration to previous presentation and/or publication must be included on the submission form.